ARLG Grand Rounds: The Why and How of the ACORN Trial Does the choice between cefepime and piperacillin-tazobactam affect the risks of acute kidney injury or neurological dysfunction in adults hospitalized with acute infection? — Presented Friday, February 27, 2026 by Drs. Edward Qian and Todd W. Rice and moderated by Dr. Sarah Doernberg  

ARLG Grand Rounds: Rational Development of Bacteriophage Cocktails Incorporating Global Harvesting Toward Novel Off-the-Shelf Antimicrobials for Multidrug-Resistant Gram-Negative ESKAPE Pathogens — Presented by Mikeljon Nikolich, PhD on Friday, December 5, 2025  

ARLG Grand Rounds: The Pittsburgh Phage Program: A Four-Year Retrospective and Future Outlook December 6, 2024 Ghady Haidar, MD, Associate Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh

ARLG Grand Rounds: There must be more to nontuberculous mycobacteria (NTM) than just Mycobacterium avium complex (MAC) October 4, 2024 Charles L. Daley, MD, Professor of Medicine, National Jewish Health, University of Colorado School of Medicine, and Icahn School of Medicine, Mt Sinai. Chief, Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, CO    

ARLG Grand Rounds: Brave new world: promise and perils of generative AI for ID professionals January 5, 2024 Ilan Schwartz, MD Associate Professor of Medicine, Division of Infectious Diseases, Duke University School of Medicine   View the event slides.

ARLG Grand Rounds: En Vogue Trends: The Good, The Bad, and The Ugly: Opportunities and Pitfalls for the ARLG October 6, 2023 Toshimitsu Hamasaki, PhD, MS Professor, George Washington University Biostatistics Center and the Department of Biostatistics and Bioinformatics Associate Director, Statistical and Data Management Center for the Antibacterial Resistance Leadership Group Scott Evans, PhD, MS Director, The Biostatistics Center Professor and Founding Chair Department of ...

ARLG Grand Rounds: Evolving Clinical Resistance and Treatment Strategies for Novel β-lactam Agents against Pseudomonas aeruginosa June 2, 2023 Ryan K. Shields, PharmD, MS Associate Professor of Medicine Co-Director, Center for Innovative Antimicrobial Therapy Co-Director, Antibiotic Management Program University of Pittsburgh       View the event slides.

ARLG Grand Rounds: Straining For the Best Outcomes: Top Controversies in C. difficile Management March 3, 2023 Michael Woodworth, MD, MSc. Assistant Professor, Division of Infectious Diseases Emory University Sarah Doernberg, MD, MAS Associate Professor in the Division of Infectious Diseases Medical Director, Adult Antimicrobial Stewardship UCSF Medical Center   View the Event Slides  

ARLG Grand Rounds: Dissecting The Epidemics of Multidrug-Resistant Organisms: A Focus on Carbapenem-Resistant Klebsiella pneumoniae February 4, 2022 Cesar A. Arias, MD, MSc, PhD Professor of Medicine, Co-director, Center for Infectious Diseases Research Houston Methodist Hospital Weill Cornell Medical College View the Event Slides  

ARLG Grand Rounds: The Microbiota and Resistome in Clinical Trials: Opportunities and Challenges May 6, 2022 Melinda M. Pettigrew, PhD Deputy Dean and Anna M. R. Lauder Professor of Epidemiology Yale School of Public Health   View the Event Slides